跳至主要内容
临床试验/NCT03326856
NCT03326856已完成2 期

Clinical Trial to Evaluate ET-01 in Subjects With Lateral Canthal Lines

Eirion Therapeutics Inc.2 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2017年10月25日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
48
试验地点
2
主要终点
Number of Participants With a Response Defined as IGA-C (Investigators Global Assessment) Score ≤ 2 and a SSA-C (Subject Self-Assessment) Score ≤ 2

研究概览

简要总结

This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).

详细描述

This product is being tested for its ability to reduce lateral canthal lines, also known as Crow's Feet.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Sequential
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
25 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 25 - 65 years of age
  • minimal to moderate Crow's Feet wrinkles at rest
  • moderate to severe Crow's Feet wrinkles on contraction
  • willingness to refrain from any product affecting skin remodeling
  • female subjects must be not pregnant and non-lactating-

排除标准

  • history of adverse reactions to any prior botulinum toxin treatments
  • history of vaccination or non-response to any prior botulinum toxin treatments
  • botulinum toxin treatment in the prior 6 months
  • present or history of neuromuscular disease, eyelid ptosis, muscle weakness, paralysis, or "dry eye"
  • history of peri-ocular surgery, brow lift or related procedures
  • procedures affecting the lateral canthal region in the prior 12 months
  • application of topical prescription medication to the treatment area
  • female subjects who are pregnant or are nursing a child

结局指标

主要结局

Number of Participants With a Response Defined as IGA-C (Investigators Global Assessment) Score ≤ 2 and a SSA-C (Subject Self-Assessment) Score ≤ 2

时间窗: Week 4

Composite of Investigators Global Assessment \& Subject Self-Assessment on contraction. Crow's Feet Wrinkle Scale where severity is scored between 0-4 (0=absent; 4=severe). The same scale is used for the Investigator's Assessment as well as the Subject's Self Assessment. To count, both assessments (on contraction) have to be "responders" defined as Score ≤ 2.

次要结局

  • Total Number of Observations With a Response Defined as IGA-C Score ≤ 2(Week 2, 4, 8,12,18)
  • Total Number of Observations With a Response Defined as SSA-C Score ≤ 2(Week 2, 4, 8,12,18)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

ET-01 in Subjects With Lateral Canthal Lines | 临床试验